Gender Differences in Melanoma Awareness, Diagnosis and Treatment: Patient-Reported Data from a Multicentre Survey in Switzerland
There is a need to understand the journey of patients with melanoma, including any associated gender differences, to identify aspects in the patient journey that could be improved. We used data collected from an online survey completed by adults with stage III or IV melanoma at three Swiss melanoma centres to understand patients' perceptions of their healthcare journeys from melanoma diagnosis to treatment and the relevance of treatment attributes (Figure 1). We identified that there is a need to improve communication about the testing process and gender differences in terms on information needs, relevance of treatment attributes and attitudes towards psychological support.
Authors
- Lara Valeska Maul (ORCID: https://orcid.org/0000-0001-9202-0073)
- Beat Siegenthaler
- David König (ORCID: https://orcid.org/0000-0003-3559-6855)
- Heinz Läubli (ORCID: https://orcid.org/0000-0002-8910-5620)
- Reinhard Dummer
- Valerio Del Prete
- Berna C. Özdemir (ORCID: https://orcid.org/0000-0002-7380-0055)
- Linda Morgan
- Johanna Mangana
- Janine Landolt
- Anastasia Musiari
- Nadine Pasche
- Cristina Lamos
- Florentia Dimitriou
- Sandra Kaiser
Institutions
- Novartis (Switzerland) (CH)
- University of Zurich (CH)
- University Hospital of Bern (CH)
- University Hospital of Basel (CH)
- University Hospital of Zurich (CH)
- Fribourg Development Agency (CH)
- Zurich University of Teacher Education (CH)
Publication Details
- Journal
- Skin Health and Disease
- Published
- 2024-09-09
- DOI
- https://doi.org/10.1002/ski2.442
- Citations
- 1
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Novartis Pharma